Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Refractory Solid Tumors × Interleukin-27 × Other solid neoplasm × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Refractory Solid Tumors 1

Interventions

Sorafenib 3 pazopanib 2 verubulin 1 trifluridine tipiracil drug combination 1 irinotecan sucrosofate 1 eribulin 1 Valproic Acid 1 Temozolomide 1 Sunitinib 1 Sirolimus 1 Irinotecan 1 Interleukin-27 1 Hydralazine 1 Erlotinib Hydrochloride 1 Azurin 1 Arsenic Trioxide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00914914 2014-10-28

Safety Study of a Cell Penetrating Peptide (p28) to Treat Solid Tumors That Resist Standard Methods of Treatment

CDG Therapeutics, Inc.

Phase 1 Completed

Other solid neoplasm

Refractory Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡